2172 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
MicroPort NeuroScientific Corp. engages in the business of research and development, manufacturing, and selling neuro-interventional medical devices. It is also involved in developing comprehensive stroke interventional treatment product line covering the three major areas of neurovascular disease namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company was founded in 2012 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
2172 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company